PDZRN3 negatively regulates BMP-2-induced osteoblast differentiation through inhibition of Wnt signaling

Molecular Biology of the Cell

Volumn 21, Issue 18, 2010, Pages 3269-3277

  Honda, Takeshi ^a   Yamamoto, Hisato ^a   Ishii, Aiko ^a   Inui, Makoto ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BETA CATENIN; BONE MORPHOGENETIC PROTEIN 2; DICKKOPF 1 PROTEIN; GLYCOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 6; PDZ PROTEIN; PROTEIN PDZRN3; PROTEIN WNTA3A; RING FINGER PROTEIN; UNCLASSIFIED DRUG; WNT PROTEIN;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; COMPETITIVE INHIBITION; CONTROLLED STUDY; CULTURE MEDIUM; CYTOSOL; ENZYME ACTIVITY; EXPOSURE; FEEDBACK SYSTEM; MOUSE; MYOTUBE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; UPREGULATION;

ALKALINE PHOSPHATASE; ANIMALS; BONE MORPHOGENETIC PROTEIN 2; CARRIER PROTEINS; CELL DIFFERENTIATION; CELLS, CULTURED; CORE BINDING FACTOR ALPHA 1 SUBUNIT; HUMANS; MICE; OSTEOBLASTS; RNA INTERFERENCE; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 77956657153     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E10-02-0117     Document Type: Article

References (32)

1. Baron, R., and Rawadi, G. (2007). Targeting the Wnt/beta-catenin pathway to regulate bone formation in the adult skeleton. Endocrinology 148, 2635-2643.
2. Blau, H. M., Pavlath, G. K., Hardeman, E. C., Chiu, C. P., Silberstein, L., Webster, S. G., Miller, S. C., and Webster, C. (1985). Plasticity of the differentiated state. Science 230, 758-766.
3. Canalis, E., Economides, A. N., and Gazzerro, E. (2003). Bone morphogenetic proteins, their antagonists, and the skeleton. Endocr. Rev. 24, 218-235.
4. Chen, Y., Whetstone, H. C., Youn, A., Nadesan, P., Chow, E. C., Lin, A. C., and Alman, B. A. (2007). Beta-catenin signaling pathway is crucial for bone morphogenetic protein 2 to induce new bone formation. J. Biol. Chem. 282, 526-533.
5. de Jesus Perez, V. A., Alastalo, T. P., Wu, J. C., Axelrod, J. D., Cooke, J. P., Amieva, M., and Rabinovitch, M. (2009). Bone morphogenetic protein 2 induces pulmonary angiogenesis via Wnt-beta-catenin and Wnt-RhoA-Rac1 pathways. J. Cell Biol. 184, 83-99.
6. Descamps, S., Arzouk, H., Bacou, F., Bernardi, H., Fedon, Y., Gay, S., Reyne, Y., Rossano, B., and Levin, J. (2008). Inhibition of myoblast differentiation by Sfrp1 and Sfrp2. Cell Tissue Res. 332, 299-306.
7. Fuentealba, L. C., Eivers, E., Ikeda, A., Hurtado, C., Kuroda, H., Pera, E. M., and De Robertis, E. M. (2007). Integrating patterning signals: Wnt/GSK3 regulates the duration of the BMP/Smad1 signal. Cell 131, 980-993.
8. Henriquez, J. P., Webb, A., Bence, M., Bildsoe, H., Sahores, M., Hughes, S. M., and Salinas, P. C. (2008). Wnt signaling promotes AChR aggregation at the neuromuscular synapse in collaboration with agrin. Proc. Natl. Acad. Sci. USA 105, 18812-18817.
9. Kamiya, N., Ye, L., Kobayashi, T., Mochida, Y., Yamauchi, M., Kronenberg, H. M., Feng, J. Q., and Mishina, Y. (2008). BMP signaling negatively regulates bone mass through sclerostin by inhibiting the canonical Wnt pathway. Development 135, 3801-3811.
10. Katagiri, T., Yamaguchi, A., Komaki, M., Abe, E., Takahashi, N., Ikeda, T., Rosen, V., Wozney, J. M., Fujisawa-Sehara, A., and Suda, T. (1994). Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J. Cell Biol. 127, 1755-1766.
11. Katoh, M., and Katoh, M. (2004). Identification and characterization of PDZRN3 and PDZRN4 genes in silico. Int. J. Mol. Med. 13, 607-613.
12. Ko, J. A., Kimura, Y., Matsuura, K., Yamamoto, H., Gondo, T., and Inui, M. (2006). PDZRN3 (LNX3, SEMCAP3) is required for the differentiation of C2C12 myoblasts into myotubes. J. Cell Sci. 119, 5106-5113.
13. Komori, T., et al. (1997). Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89, 755-764.
14. Kretzschmar, M., Doody, J., and Massague, J. (1997). Opposing BMP and EGF signalling pathways converge on the TGF-beta family mediator Smad1. Nature 389, 618-622.
15. Li, X., Zhang, Y., Kang, H., Liu, W., Liu, P., Zhang, J., Harris, S. E., and Wu, D. (2005). Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling. J. Biol. Chem. 280, 19883-19887.
16. Lu, W., Kim, K. A., Liu, J., Abo, A., Feng, X., Cao, X., and Li, Y. (2008). R-spondin1 synergizes with Wnt3A in inducing osteoblast differentiation and osteoprotegerin expression. FEBS Lett. 582, 643-650.
17. Lu, Z., Je, H. S., Young, P., Gross, J., Lu, B., and Feng, G. (2007). Regulation of synaptic growth and maturation by a synapse-associated E3 ubiquitin ligase at the neuromuscular junction. J. Cell Biol. 177, 1077-1089.
18. Mbalaviele, G., Sheikh, S., Stains, J. P., Salazar, V. S., Cheng, S. L., Chen, D., and Civitelli, R. (2005). Beta-catenin and BMP-2 synergize to promote osteoblast differentiation and new bone formation. J. Cell Biochem. 94, 403-418.
19. Milat, F., and Ng, K. W. (2009). Is Wnt signalling the final common pathway leading to bone formation? Mol. Cell Endocrinol. 310, 52-62.
20. Miyazono, K., Kamiya, Y., and Morikawa, M. (2010). Bone morphogenetic protein receptors and signal transduction. J. Biochem. 147, 35-51.
21. Moustakas, A., and Heldin, C. H. (2005). Non-Smad TGF-beta signals. J. Cell Sci. 118, 3573-3584.
22. Nakashima, A., Katagiri, T., and Tamura, M. (2005). Cross-talk between Wnt and bone morphogenetic protein 2 (BMP-2) signaling in differentiation pathway of C2C12 myoblasts. J. Biol. Chem. 280, 37660-37668.
23. Prockop, D. J. (1997). Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276, 71-74.
24. Rawadi, G., Vayssiere, B., Dunn, F., Baron, R., and Roman-Roman, S. (2003). BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop. J. Bone Miner. Res. 18, 1842-1853.
25. Rochat, A., Fernandez, A., Vandromme, M., Moles, J. P., Bouschet, T., Carnac, G., and Lamb, N. J. (2004). Insulin and wnt1 pathways cooperate to induce reserve cell activation in differentiation and myotube hypertrophy. Mol. Biol. Cell 15, 4544-4555.
26. Sato, M. M., Nakashima, A., Nashimoto, M., Yawaka, Y., and Tamura, M. (2009). Bone morphogenetic protein-2 enhances Wnt/beta-catenin signaling-induced osteoprotegerin expression. Genes Cells 14, 141-153.
27. Semenov, M., Tamai, K., and He, X. (2005). SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor. J. Biol. Chem. 280, 26770-26775.
28. Tamai, K., Zeng, X., Liu, C., Zhang, X., Harada, Y., Chang, Z., and He, X. (2004). A mechanism for Wnt coreceptor activation. Mol. Cell 13, 149-156.
29. Vaes, B. L., et al. (2005). Microarray analysis reveals expression regulation of Wnt antagonists in differentiating osteoblasts. Bone 36, 803-811.
30. Wang, J., Ruan, N. J., Qian, L., Lei, W. L., Chen, F., and Luo, Z. G. (2008). Wnt/beta-catenin signaling suppresses Rapsyn expression and inhibits acetylcholine receptor clustering at the neuromuscular junction. J. Biol. Chem. 283, 21668-21675.
31. Zhang, Y. E. (2009). Non-Smad pathways in TGF-beta signaling. Cell Res. 19, 128-139.
32. Zhao, G. Q. (2003). Consequences of knocking out BMP signaling in the mouse. Genesis 35, 43-56.